PALLD

Palladin (PALLD) is a cytoskeletal scaffolding protein that crosslinks and bundles actin filaments through its immunoglobulin domains and orchestrates actin-dependent processes in diverse cell types including cardiomyocytes, macrophages, megakaryocytes, and Sertoli cells. Its Ig3 domain directly bundles F-actin, an activity inhibited by PI(4,5)P2 binding at residues K38/K51, and the same domain mediates interaction with STAT3 to promote Y705 phosphorylation and nuclear translocation required for megakaryocyte polyploidization and proplatelet formation (PMID:27487483, PMID:38813732). In macrophages, PALLD recruits the OCRL phosphatase to nascent phagosomes to couple PI(4,5)P2 hydrolysis with actin depolymerization for phagosome closure, and in fetal liver it is specifically required in macrophages for erythroblastic island formation (PMID:28739877, PMID:17431131). Cardiac-specific ablation in adult mice causes progressive dilated cardiomyopathy with intercalated disc disorganization, consistent with its interactions with CARP/Ankrd1 and FHOD1 at intercalated disc structures (PMID:36927816).

1. 2006 Medium

   The question of whether palladin directly controls actin organization and cell motility was addressed by showing that a P239S missense mutation disrupts actin bundle assembly and increases migration, establishing palladin as a functional regulator of the actin cytoskeleton.

   Evidence Transfection of wild-type and P239S mutant palladin into HeLa cells with cytoskeletal and migration analysis

   PMID:17194196

   Open questions at the time

   • Single mutation studied; structure-function relationship for actin bundling not mapped
   • No in vivo validation of P239S phenotype
2. 2007 High

   The cell-type-specific role of palladin in hematopoiesis was resolved: palladin-null mice revealed that palladin is required specifically in macrophages — not erythroblasts — for erythroblastic island formation in fetal liver, establishing a non-redundant scaffolding function in tissue-resident macrophages.

   Evidence Palld knockout mice with reciprocal in vitro island reconstitution assays using wild-type and null macrophages/erythroblasts

   PMID:17431131

   Open questions at the time

   • Molecular mechanism by which palladin enables macrophage-erythroblast adhesion is unknown
   • Postnatal bone marrow erythropoiesis role not tested
3. 2013 Medium

   An unexpected nuclear function was uncovered when the 140 kDa PALLD isoform in Sertoli cells was found to undergo cleavage, with its C-terminal fragment localizing to the nucleus at puberty onset, raising the question of whether palladin has non-cytoskeletal roles.

   Evidence Immunofluorescence and subcellular fractionation with isoform-specific antibodies in rat Sertoli cells

   PMID:23559268

   Open questions at the time

   • Cleavage protease not identified
   • Nuclear function of the C-terminal fragment unknown
   • Single lab, single study
4. 2014 Medium

   The signaling axis controlling PALLD nuclear localization in Sertoli cells was identified: FSH receptor signaling through cAMP regulates actin dynamics, which in turn determines whether PALLD resides in the nucleus or cytoplasm, linking an endocrine signal to palladin subcellular distribution.

   Evidence Primary Sertoli cell culture with cAMP and actin-depolymerizing treatments; FSH receptor, LH receptor, and androgen receptor mutant mice

   PMID:24989903

   Open questions at the time

   • Direct nuclear target or transcriptional role of nuclear PALLD fragment not identified
   • Mechanism coupling actin state to PALLD localization not resolved
5. 2016 High

   The biochemical basis of palladin's actin-bundling activity and its lipid regulation were defined: PI(4,5)P2 binds the Ig3 domain at K38/K51 and inhibits actin crosslinking and polymerization, providing a direct molecular switch linking membrane phosphoinositide signaling to cytoskeletal remodeling.

   Evidence In vitro actin polymerization/bundling assays, NMR titration, molecular docking, and K38 charge-neutralization mutagenesis

   PMID:27487483

   Open questions at the time

   • In vivo relevance of PI(4,5)P2-mediated inhibition not tested
   • Whether other PIP species regulate palladin is unknown
6. 2017 High

   Palladin's role in innate immunity was established: it facilitates phagocytosis by regulating actin polymerization and c-Src activation at particle binding sites, and recruits the PI(4,5)P2 phosphatase OCRL to nascent phagosomes to enable actin depolymerization and phagosome closure, directly linking palladin to phosphoinositide turnover at membranes.

   Evidence PALLD knockdown in myeloid leukemia cells; live-cell imaging; co-immunoprecipitation of PALLD with OCRL; phagocytosis assays

   PMID:28739877

   Open questions at the time

   • Domain on PALLD mediating OCRL recruitment not mapped
   • Role in in vivo infection models not tested
7. 2022 Medium

   Beyond cytoskeletal scaffolding, palladin was shown to activate Wnt/β-catenin signaling and promote cancer stem cell-like properties in lung cancer cells, with pathway inhibitor rescue confirming pathway dependence.

   Evidence Overexpression and knockdown in NSCLC cell lines; sphere-forming assays; Wnt inhibitor treatment; xenograft models

   PMID:36047666

   Open questions at the time

   • Mechanism by which an actin-binding scaffold activates Wnt/β-catenin is unclear
   • Not replicated in non-cancer cell types
8. 2023 High

   The essential cardiac role of palladin was demonstrated: inducible cardiomyocyte-specific knockout in adult mice caused progressive dilated cardiomyopathy with intercalated disc defects and fibrosis, and yeast two-hybrid identified CARP/Ankrd1 and FHOD1 as N-terminal binding partners, placing palladin as a structural organizer at intercalated discs.

   Evidence Conditional and inducible cardiomyocyte-specific PALLD KO mice; echocardiography; histology; single-cell contractility; yeast two-hybrid

   PMID:36927816

   Open questions at the time

   • Which PALLD isoform is critical for cardiac function not resolved
   • CARP/FHOD1 interactions not validated by endogenous co-IP in cardiomyocytes
9. 2024 High

   Palladin was established as a direct activator of STAT3 signaling in megakaryocytes: its Ig3 domain binds the STAT3 DNA-binding and SH2 domains, promoting Y705 phosphorylation and nuclear translocation necessary for proplatelet formation, with a PALLD-derived peptide capable of rescuing platelet production in vivo.

   Evidence Megakaryocyte/platelet-specific Palld KO mice; immunoprecipitation; domain mapping; phosphorylation assays; peptide rescue in vivo

   PMID:38813732

   Open questions at the time

   • How an Ig-domain scaffold promotes kinase-mediated STAT3 phosphorylation mechanistically is not resolved
   • Therapeutic peptide specificity and off-target effects not characterized
10. 2025 Medium

    Post-transcriptional regulation of PALLD was identified: STAU2 directly binds PALLD mRNA to regulate its expression and promotes pancreatic cancer metastasis through an EMT pathway involving PALLD and IQGAP1.

    Evidence RNA-binding protein immunoprecipitation; STAU2 siRNA/ASO knockdown; Western blot; in vivo xenograft

    PMID:40539383

    Open questions at the time

    • Whether STAU2 stabilizes or destabilizes PALLD mRNA not clarified
    • Direct versus indirect regulation of EMT by PALLD not distinguished

• Key unresolved questions include how palladin's actin-bundling and signaling scaffolding functions are coordinated across cell types, the identity of the protease that cleaves the 140 kDa isoform in Sertoli cells, the nuclear function of palladin's C-terminal fragment, and the structural basis of the Ig3 domain's dual roles in actin binding, PI(4,5)P2 sensing, and STAT3 activation.
• No high-resolution structure of full-length palladin or palladin-actin complex
• Isoform-specific functions in different tissues not systematically compared
• No Mendelian disease definitively attributed to PALLD loss-of-function mutations in humans